Effect of Antibiotic Choice On ReNal Outcomes (ACORN)

NCT05094154 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2634

Enrollment

OTHER

Sponsor class

Conditions

Sepsis
AKI
Neurotoxicity

Interventions

DRUG: anti-pseudomonal cephalosporin
DRUG: anti-pseudomonal penicillin

Sponsor

Vanderbilt University Medical Center